Back to Search Start Over

An overview of lipoxygenase inhibitors with approach of in vivo studies.

Authors :
Orafaie A
Mousavian M
Orafai H
Sadeghian H
Source :
Prostaglandins & other lipid mediators [Prostaglandins Other Lipid Mediat] 2020 Jun; Vol. 148, pp. 106411. Date of Electronic Publication: 2020 Jan 14.
Publication Year :
2020

Abstract

Lipoxygenases (LOXs) are enzymes which found in organisms that catalyze the peroxidation of polyunsaturated fatty acids (Arachidonic acid, Linoleic acid). The key role of the mentioned enzymes and their metabolites in formation of sensitivities, inflammations, many of cancers (prostate, breast, etc), obesity, diabetes and atherosclerosis had been demonstrated. This review aimed to focus on research findings introducing proved LOXs (5/12/15-LOX) inhibitors, which have been involved in in vivo studies, and discuss on their sources, chemical structures and medicinal applications. By this subject selection, we would introduce the possible LOXs inhibitors (5/12/15-LOX) with special physiological and metabolic levels and open a vision in molecular target selection for the readers.<br /> (Copyright © 2020 Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1098-8823
Volume :
148
Database :
MEDLINE
Journal :
Prostaglandins & other lipid mediators
Publication Type :
Academic Journal
Accession number :
31953016
Full Text :
https://doi.org/10.1016/j.prostaglandins.2020.106411